1998
DOI: 10.1128/jvi.72.5.4448-4453.1998
|View full text |Cite
|
Sign up to set email alerts
|

PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo

Abstract: The human cdc2-related kinase PITALRE is the catalytic component of TAK, the Tat-associated kinase. Previously, we have proposed that TAK is a cellular factor that mediates Tat transactivation function. Here we demonstrate that transient overexpression of PITALRE specifically squelches Tat-1 activation of both a transfected and an integrated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR), suggesting that PITALRE mediates Tat function as a multiprotein complex. A catalytic mutant of PITA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
34
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 113 publications
(36 citation statements)
references
References 49 publications
2
34
0
Order By: Relevance
“…In addition to P-TEFb (Yu et al, 2008), CaM has been reported to regulate the expression of PCNA (Maga et al, 1997) and this may be the reason that W-7 treatment inhibited PCNA expression more than HIV-1 LTR expression. Although, P-TEFb has been reported to be recruited by HTLV-1 Tax to activate HTLV-1-LTR (Zhou et al, 2006;Cho et al, 2010), we have reported that a dominantnegative Cdk9 protein does not inhibit Tax transactivation (Gold et al, 1998). Our finding that W-7 reduces Cdk9 T-loop phosphorylation levels, but not Tax activation function are consistent with our previous result with the dominant-negative Cdk9 protein and suggest that the mechanism of Tax transactivation is not as stringently dependent upon P-TEFb as that of the HIV-1 Tat protein.…”
Section: Cdk9 Protein Function Is Modulated By Cdk9 T-loop Phosphorylmentioning
confidence: 56%
See 1 more Smart Citation
“…In addition to P-TEFb (Yu et al, 2008), CaM has been reported to regulate the expression of PCNA (Maga et al, 1997) and this may be the reason that W-7 treatment inhibited PCNA expression more than HIV-1 LTR expression. Although, P-TEFb has been reported to be recruited by HTLV-1 Tax to activate HTLV-1-LTR (Zhou et al, 2006;Cho et al, 2010), we have reported that a dominantnegative Cdk9 protein does not inhibit Tax transactivation (Gold et al, 1998). Our finding that W-7 reduces Cdk9 T-loop phosphorylation levels, but not Tax activation function are consistent with our previous result with the dominant-negative Cdk9 protein and suggest that the mechanism of Tax transactivation is not as stringently dependent upon P-TEFb as that of the HIV-1 Tat protein.…”
Section: Cdk9 Protein Function Is Modulated By Cdk9 T-loop Phosphorylmentioning
confidence: 56%
“…Furthermore, to verify if the effect of inhibiting Ca 2þ signaling is specific for promoters that have a strong requirement for P-TEFb function, we used a HTLV-1-LTR luciferase expression plasmid in conjunction with its transactivator Tax. We have previously shown that a dominant-negative Cdk9 protein does not inhibit Tax transactivation of the HTLV-1 LTR unlike its strong inhibition of Tat transactivation of the HIV-1 LTR, suggesting that Tax function may not be strictly dependent upon P-TEFb (Gold et al, 1998).…”
Section: Inhibitors Of Ca 2r Signaling Pathway Components Reduce Cdk9mentioning
confidence: 99%
“…Tat copuri es with a nuclear Tat-associated kinase (TAK) (27 ), which corresponds to the kinase subunit of the P-TEFb complex (28,29). The catalytic subunit of this Cdc2-related kinase is PITALRE/ CDK9 (30).…”
Section: Tat and Transcriptional Elongationmentioning
confidence: 99%
“…As we do not have access to a bTat-specific antiserum, we performed this mutational analysis in the context of an HIV-1 Rev-bTat fusion protein that can be readily detected using an anti-Rev antiserum. Further, in the case of hTat, we and others have previously demonstrated that an hTat-Rev fusion protein can potently activate an HIV-1 LTR in which the hTAR element has been replaced with Rev response element stem-loop IIB (SLIIB), the RNA target for HIV-1 Rev (19,26,34). As shown in Fig.…”
Section: Resultsmentioning
confidence: 91%
“…This binding, which is highly cooperative, is mediated by direct interactions between the Tat basic domain and a TAR RNA bulge and, most probably, between CycT1 and the terminal TAR loop (12,26,32,38,41). Subsequently, the cdk9 component of P-TEFb is believed to activate efficient elongation from the HIV-1 LTR promoter by phosphorylating the carboxyterminal domain of initiated RNA polymerase II molecules, and also possibly other substrates (3, 10, 19,27,35,38,[40][41][42]. Recent evidence demonstrating that the HIV-1 LTR can be fully activated if P-TEFb is recruited to the promoter by tethering to a heterologous RNA target (3,19) suggests that P-TEFb recruitment, either by Tat or by some other means, is both necessary and sufficient for activation of viral transcription.…”
Section: Discussionmentioning
confidence: 99%